AstraZeneca falls over 2% after hours due to disappointing phase III clinical trial results
智通财经2026/09/11 20:36Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
AstraZeneca's stock price fell more than 2% after hours due to disappointing results from its Phase III clinical trial.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Hedge funds halved their short positions on the yen before Ueda's statement
智通财经•2026/09/11 21:01
AstraZeneca Says Late-Stage Etcamah Breast-Cancer Trial Misses Main Goal
MT newswire•2026/09/11 20:58
Crypto prices
More
Bitcoin
BTC
$77,329.01
+0.12%
Ethereum
ETH
$2,530.99
+2.82%
Tether USDt
USDT
$0.9997
+0.01%
BNB
BNB
$725.12
+1.41%
XRP
XRP
$1.36
+0.55%
USDC
USDC
$0.9999
+0.00%
Solana
SOL
$102.53
+2.50%
TRON
TRX
$0.3385
-0.23%
Hyperliquid
HYPE
$80.57
+0.13%
Zcash
ZEC
$1,183.03
+4.73%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now